New Video Available: Regenerative Medicine Panel at OneMedForum SF 2014

Posted by Laura Swartz

January 21, 2014 at 10:06 AM

If you missed the "Extending Life and Limb" workshop on regenerative medicine held last week at the OneMedForum conference in San Francisco, you can watch the full panel discussion on YouTube at the link below.

Read More

Topics: Crystal Research Associates, OneMedForum

Regenerative Medicine "Extending Life and Limb" Workshop

Posted by Laura Swartz

January 13, 2014 at 4:48 PM

If you are in San Francisco today for the JP Morgan Healthcare Conference, the Biotech Showcase, or the 7th annual OneMedForum, we welcome you to stop by the Westin San Francisco on Market Street to visit our booth and hear Crystal Research CEO Jeffrey Kraws speak on regenerative medicine.

Read More

Topics: Crystal Research Associates, OneMedForum

We have an app and a brand new website!

Posted by Laura Swartz

January 13, 2014 at 12:00 PM

Crystal Research Associates is pleased to announce today that we have officially launched our mobile app and our new website. Take a look around at some of the changes...it is now easier than ever to sign up for research notifications and even start a discussion with us about your business's strategic needs. We have also recently expanded our line of products and services, which is now reflected throughout the site.

Read More

Topics: Crystal Research Associates, IR App

Crystal Research CEO Speaks With ABC News/Al Jazeera on JNJ Settlement

Posted by Laura Swartz

November 7, 2013 at 1:18 PM

On Tuesday, Jeffrey Kraws, senior pharmaceutical analyst at Crystal Research Associates, spoke with ABC News and Al Jazeera television regarding Johnson & Johnson’s $2.2 billion settlement for unlawfully marketing Risperdal, an anti-psychotic drug. Risperdal is FDA approved to treat schizophrenia but was illegally marketed to doctors and nursing homes as a treatment for elderly patients with dementia. The settlement included criminal fines totaling $485 million and civil fines of over $1.7 billion, which included payments to whistleblowers.  

Mr. Kraws spoke with Al Jazeera from New York City in a live segment airing overseas shortly after 4 PM ET on Tuesday. Among other questions, Kraws explains some of the ethical and brand image ramifications of JNJ’s actions and answers how the drug giant was able to use a system of internal as well as third-party players, kickbacks, and unsubstantiated product claims put forth over the years despite repeated warnings from the FDA.  

Read More

Topics: Crystal Research Associates, Newsworthy Events, Al Jazeera, ABC News

FULL VIDEO (Reuters TV): Biotech Stocks To Watch and More

Posted by Colleen Koski

August 15, 2013 at 1:25 PM

Last week, Jeff Kraws sat down with Rhonda Schaffler at Reuters to discuss opportunities and trends in the biotech space. Mr. Kraws is a veteran Wall Street sell-side analyst with more than 20 years of experience and is also cofounder and CEO of Crystal Research Associates. If you enjoyed the short clip of this interview released earlier this week, the full segment (available below) goes into more detail on individual biotech stocks and the events every investor should be watching out for.

Read More

Topics: AtheroNova, Crystal Research Associates, Unilife Corp., biotech, MetaStat, Reuters

Jeff Kraws Talks Opportunities for Biotech Investors

Posted by Laura Swartz

August 13, 2013 at 11:47 AM

Biotechnology--the use of living organisms or other biological systems in the manufacture of drugs or other products--has emerged as a critical sector for healthcare investors over the past several years. In 2012 alone, the biotech sector grew over 40% according to S&P Capital IQ. Biotech is expected to remain a hot market going forward, with considerable room for more growth. Last week, biotech firm Intrexon Corp. (XON-NYSE) made its IPO debut at $16/share and immediately soared 38%. Nearly double its IPO price, Intrexon opened at $29.99 this morning, August 13th. 

Read More

Topics: Crystal Research Associates, Newsworthy Events, biotech

Fund Managers Unplugged: Industry Veterans Predict Stock Performance

Posted by Laura Swartz

June 24, 2013 at 10:20 AM

If you will be at OneMedForumNY 2013 this week, you are invited to attend the Fund Managers Unplugged panel as veteran fund managers, including Crystal Research CEO Jeffrey Kraws, explore the state of financing in the life sciences arena and discuss the successful “picks” made during OneMedForumSF 2013 this past January.

Check out our YouTube page for video highlights from the first “Fund Managers Unplugged” event held in January 2013, which include Jeff Kraws' initial stock picks, Gilead Sciences (GILD-NASDAQ) and ISIS Pharmaceuticals (ISIS-NASDAQ), which are up 23% and 107% respectively since the first panel!

Read More

Topics: Crystal Research Associates, OneMedForum

Join us at the 4th Annual OneMedForum 2013 in New York: June 26-27

Posted by Laura Swartz

June 11, 2013 at 12:30 PM

Read More

Topics: Crystal Research Associates, OneMedForum

Crystal Research Enters into Strategic Partnership with MZ Group

Posted by Colleen Koski

May 22, 2013 at 9:33 AM

"We are very excited to partner with a great organization like Crystal Research. With fewer sell-side firms capable and willing to provide research coverage for small and microcap stocks, we see tremendous value in independent research. After seeing Jeff and his team work with a few of our clients, we were extremely impressed with their diligent process and comprehensive reports. Forming this partnership allows us to leverage our collective strengths to help investors fully understand our client's stories and to increase investor and media awareness and interest in our client's companies."

 

Read More

Topics: Crystal Research Associates, MZ Group

CEO Jeff Kraws Featured on Reuters' State of the Union Roundtable

Posted by Laura Swartz

February 13, 2013 at 3:14 PM

This morning, Crystal Research's CEO Jeff Kraws was invited to participate in a roundtable discussion to analyze how investors should be reacting to President Obama's State of the Union address. The segment was hosted by Thomson Reuters' Rhonda Schaffler and also featured David Joy, Chief Market Strategist of Ameriprise Financial, and Craig Irwin, Senior Vice President at Wedbush Securities.

Read More

Topics: Bridgelux, Crystal Research Associates, nanotechnology, green infrastructure, Unilife Corp., MetaStat

NEW INDUSTRY REPORT: Guide for Investing in Green Infrastructure

Posted by Laura Swartz

January 15, 2013 at 10:25 AM

Read More

Topics: Crystal Research Associates, nanotechnology, built environment, green infrastructure

Today, January 9, 2013 at 4 PM: "Fund Managers Unplugged"

Posted by Laura Swartz

January 9, 2013 at 9:43 AM

If you are at the OneMedForum conference in San Francisco today, we invite you to join us for the Special Session: Fund Managers Unplugged” panel occurring at 4 PM at the Sir Francis Drake Hotel.

Crystal Research Associates' CEO Jeffrey Kraws will be moderating the discussion, accompanied by panelists Mr. Dennis J. Purcell, Senior Managing Partner at Aisling Capital with approximately $1.7 billion in assets under management; Dr. J. Misha Petkevich, Co-founder of BladeRock Capital and former Chairman and CEO of The Petkevich Group, LLC; and Mr. William S. Slattery, Partner at Deerfield Management Company, L.P. where he focuses on biotechnology investments.

Read More

Topics: Crystal Research Associates, OneMedForum

"Special Session: Fund Managers Unplugged" at OneMedForum SF 2013

Posted by Laura Swartz

January 2, 2013 at 1:12 PM

CEO Jeff Kraws selected to moderate a Special Session "Fund Managers Unplugged" at the 6th Annual OneMedForum Conference in San Francisco on Wednesday, January 9, 2013.

Read More

Topics: Crystal Research Associates, OneMedForum

Happy Holidays from Crystal Research Associates

Posted by Laura Swartz

December 18, 2012 at 10:05 AM

Season's Greetings!

From all of us here at Crystal Research Associates, we would like to wish you and your family a joyful holiday season and a prosperous new year!

Read More

Topics: Crystal Research Associates, OneMedForum

Crystal Research Associates to Sponsor 6th Annual OneMedForum

Posted by Colleen Koski

October 16, 2012 at 12:22 PM

Partnership with OneMedPlace provides research and expanded media coverage to client companies

Read More

Topics: Crystal Research Associates, OneMedForum

About This Blog

We provide investor-based research and corporate communications services to companies worldwide. Visit our About Us page to learn more.

Posts by Topic